Use of insulin-like growth factor in the healing of open wounds in diabetic and non-diabetic rats

Acta Cirurgica Brasileira

Volumn 29, Issue 2, 2014, Pages 125-131

  Achar, Rosi Aparecida Nunes ^a   Silva, Thiago Couto ^a   Achar, Eduardo ^a   Martines, Roosecelis Brasil ^b   Machado, José Lucio Martins ^a  

^a MASTERS AND DOCTORAL PROGRAMS IN PHYSICAL THERAPY   (Brazil)

^b INSTITUTO ADOLFO LUTZ   (Brazil)

Author keywords

Alloxan; Diabetes mellitus; Insulin like growth factor I; Myofibroblasts; Rats; Wound healing

Indexed keywords

ALLOXAN; ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN FIBER; DIAMINOBENZIDINE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; MOLECULAR MARKER; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; EPITHELIZATION; FEEDING DISORDER; HISTOPATHOLOGY; HYPEREMIA; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; MALE; MONONUCLEAR CELL; MYOFIBROBLAST; NONHUMAN; POLYMORPHONUCLEAR CELL; POLYURIA; PROTEIN EXPRESSION; RAT; SKIN DEFECT; TISSUE NECROSIS; TISSUE REPAIR; WEIGHT REDUCTION; WOUND HEALING;

ACTINS; ADMINISTRATION, TOPICAL; ALLOXAN; ANIMALS; CELL PROLIFERATION; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR I; MALE; MYOFIBROBLASTS; RATS, WISTAR; REPRODUCIBILITY OF RESULTS; SKIN CREAM; TIME FACTORS; TREATMENT OUTCOME; WOUND HEALING;

EID: 84895102762     PISSN: 01028650     EISSN: 16782674     Source Type: Journal    
DOI: 10.1590/S0102-86502014000200009     Document Type: Article

References (20)

1. Bruhn-Olszewska B, Korzon-Burakowska A, Gabig-Cimińska M, Olszewski P, Wegrzyn A, Jakóbkiewicz-Banecka J. Molecular factors involved in the development of diabetic foot syndrome. Acta Biochim Pol. 2012;59(4):507-513.
2. Abo El Asrar MA, Elbarbary NS, Elshennawy DE, Omar AM. Insulin-like growth factor-1 cytokines cross-talk in type 1 diabetes mellitus: relationship to microvascular complications and bone mineral density. Cytokine. 2012;59(1):86-93.
3. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev. 2003;83(3):835-870.
4. Ching YH, Sutton TL, Pierpont YN, Robson MC, Payne WG. The use of growth factors and other humoral agents to accelerate and enhance burn wound healing. Eplasty. 2011;11:429-449.
5. Martin P. Wound healing-aiming for perfect skin regeneration. Science. 1997;276:75-81.
6. Brown Dl, Kane CD, Chernausek SD, Greenhalgh DG. Differential expression and localization of insulin-like growth factors I and II in cutaneous wounds of diabetic and nondiabetic mice. Am J Pathol. 1997;151(3):715-724.
7. Desmouliere A. Factors influencing myofibroblast differentiation during wound healing and fibrosis. Cell Biol Int. 1995;19(5):471-476.
8. Novosyadlyy R, Dudas J, Pannem R, Ramadori G, Scharf JG. Crosstalk between PDGF and IGF-1 receptors in rat liver myofibroblasts: implication for liver fibrogenesis. Lab Invest. 2006;86(7):710-723.
9. Kwiecinski M, Elfimova N, Noetel A, Töx U, Steffen HM, Hacker U, Nischt R, Dienes HP, Odenthal M. Expression of platelet-derived growth factor-C and insulin-like growth factor I in hepatic stellate cells is inhibited by miR-29. Lab Invest. 2012;92(7):978-987.
10. Hinz B, Phan SH, Thannickal VJ, Prunotto M, Desmoulière A, Varga J, De Wever O, Mareel M, Gabbiani G. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am J Pathol. 2012;180(4):1340-1355.
11. Lerco MM, Spadella CT, Machado JLM, Schellini SA, Padovani CR. Experimental alloxan diabetes-induced: a model for clinical and laboratory studies in rats. Acta Cir Bras. 2003;18:132-142.
12. Marikovsky M, Vogt P, Eriksson E, Rubin JS, Taylor WG, Joachim S, Klagsbrun M. Wound fluid-derived heparin-binding EGF-like growth factor (HB-EGF) is synergistic with insulin-like growth factor-I for Balb/MK keratinocyte proliferation. J Invest Dermatol. 1996;106(4):616-621.
13. Robertson JG, Belford DA, And Ballard FJ. Clearance of IGFs and insulin from wounds: effect of IGF-binding protein interactions. Am J Physiol. 1999;276(4):663-671.
14. Steenfos HH, Jansson JO. Gene expression of insulin-like growth factor-I and IGF-1 receptor during wound healing in rats. Eur J Surg. 1992;158(6-7):327-331.
15. Jennische E, Skottner A, Hansson HA. Dynamic changes in insulin-like growth factor I immunoreactivity correlate to repair events in rat ear after freeze-thaw injury. Exp Mol Pathol. 1987;47(2):193-201.
16. Bitar MS, Labbad ZN. Transforming growth factor-beta and insulin-like growth factor-I in relation to diabetes-induced impairment of wound healing. J Surg Res. 1996;61(1):113-119.
17. Blakytny R, Jude EB, Martin Gibson J, Boulton AJ, Ferguson MW. Lack of insulin-like growth factor 1 (IGF1) in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers. J Pathol. 2000;190(5):589-594.
18. Mandelbaum SH, Di Santis EP, Mandelbaum MHS. Cicatrização: conceitos atuais e recursos auxiliares. An Bras Dermatol. 2003;78(4):393-410.
19. Hinz B, Celetta G, Tomasek JJ, Gabbiani G, Chaponnier C. Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell. 2001;12(9):2730-2741.
20. Bogatkevich GS, Tourkina E, Abrams CS, Harley RA, Silver RM, Ludwicka-Bradley A. Contractile activity and smooth muscle alpha actin organization in thrombin-induced human lung myofibroblasts. Am J Physiol Lung Cell Mol Physiol. 2003;285(2):334-343.